Skip to content

Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine

Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine - Prevalence, Concomitant Conditions and Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05247060
Acronym
IP-OP
Enrollment
1000
Registered
2022-02-18
Start date
2018-10-16
Completion date
2024-02-20
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalization

Keywords

orthostatic hypotension, Internal Medicine

Brief summary

The two scientific societies FADOI and SIIA have decided to start a collaborative study protocol that, through the application of a simple and homogeneous method to diagnose orthostatic hypotension, aims to estimate prevalence, conditions associates and outcomes in a cohort of patients admitted to Internal Medicine Departments and with known or newly diagnosed arterial hypertension.

Detailed description

The IP-OP study, is an observational, multicenter, prospective, national study that provides for the involvement of 34 Operating Units of Internal Medicine, and the recording of data relating to 1000 hospitalized adults. The clinical data of all consecutive patients diagnosed with arterial hypertension hospitalized in Internal Medicine and able to take the erect station will be collected.

Interventions

There will not be any experimental intervention. The study will be conducted according with normal clinical practice

Sponsors

Fadoi Foundation, Italy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Presence of arterial hypertension (known or discovered at hospitalization) * Signature of Informed Consent

Exclusion criteria

* Patients unable to take the standing station for a few minutes

Design outcomes

Primary

MeasureTime frameDescription
clinical conditions ( physiological parameters, copatologies) associated with the presence of orthostatic hypotension4 monthsIdentification, through a multivariate analysis, of the clinical conditions associated with the presence of orthostatic hypotension in the population of hypertensive patients admitted to Internal Medicine

Secondary

MeasureTime frameDescription
Gender differences in prevalence and conditions associated with orthostatic hypotension4 monthsAssessment of possible gender differences in prevalence and conditions associated with orthostatic hypotension
Level of cognitive impairment of the subjects studied, and relationship with orthostatic hypotension4 monthsEvaluation in the initial visit of the level of cognitive impairment of the subjects studied, and relationship with orthostatic hypotension
Relationship between orthostatic hypotension and a Fragility Index4 monthsEvaluation of the relationship between orthostatic hypotension and a Fragility Index
Prevalence of orthostatic hypotension4 monthsPrevalence of orthostatic hypotension among hypertensive patients admitted to Internal Medicine
Prescription drugs on the presence and severity of hypotension Orthostatic4 monthsAnalysis of the impact of prescription drugs on the presence and severity of hypotension Orthostatic
Presence of orthostatic hypertension4 monthsEvaluation of the presence of orthostatic hypertension
After 6-12-24-36 months from the index hospitalization, of the state of health of all the subjects evaluated6-12-24-36 months from hospitalizationEvaluation, after 6-12-24-36 months from the index hospitalization, of the state of health of all the subjects evaluated, reporting the possible onset of falls, major cardiovascular events (stroke, TIA, myocardial infarction, arrhythmias) or death.
Relationship between orthostatic hypotension and comorbidity by calculating the index of Charlson comorbidity4 monthsEvaluation of the relationship between orthostatic hypotension and comorbidity by calculating the index of Charlson comorbidity

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026